Return to Search
Implementation of Biosimilar Claim Modifiers
Guidance for the Change Request ( CR) instructs contractors to include an appropriate modifier that identifies the manufacturer of a specific product for biosimilar biological products assigned to a common HCPCS code.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: September 04, 2015
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.